Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GWIT Study
NCT05355272Phase 2Recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin in Gulf War syndrome (GWS), adult growth hormone deficiency (AGHD), sponsored by Baylor College of Medicine. Started Mar 2024; status: recruiting.
02
Drugs
somatropin
03
Conditions
Gulf War syndrome (GWS)adult growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on NCT05355272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05355272.